Dr. Arani, a published author and esteemed physician, is widely acknowledged as a leading expert in the diagnosis and treatment of sexually transmitted diseases, with a particular focus on HPV. Regarded as a pioneer in the field, he has developed innovative strategies, classifications, and treatment methods for managing HPV-related tumors. Dr. Arani earned his MD degree from RUSM in 1999 and completed clinical training at the Mayo Clinic Hospital and Maricopa Medical Center in Arizona.

In 2002, Dr. Arani received a faculty appointment as instructor at Loma Linda University School of Medicine, advancing to the position of Assistant Clinical Professor of Medicine in 2003. Demonstrating a strong commitment to improving healthcare delivery and a keen interest in public health and epidemic diseases, he founded one of California's largest STD/HPV diagnostic and treatment institutions in 2004. Additionally, in 2006, he established D.A.M.L., an exclusive laboratory specializing in sexually transmitted infectious diseases, providing accurate and rapid test results for various STDs in the U.S.

Dr. Arani's dedication to quality care and public health extended to his recommendations to the White House in 2006. In 2007, he introduced the BCR microsurgical destruction method, a three-step approach promising complete eradication of HPV-related infected benign epithelial tumors, lesions, genital, and anal warts. Recognized by numerous news and media networks, he has contributed expert insights as a forefront physician in the diagnosis and treatment of STDs and human papillomavirus.

In 2013, Dr. Arani published "HPV, The Silent Intruder," a comprehensive 19-chapter review of Human Papillomavirus and Condyloma Acuminatum, showcasing his innovative approach to treating HPV. This work significantly impacted the field and played a crucial role in curbing the epidemic, as evidenced by a publication in 2018. The trademark registration for HPV BCR, filed, further solidifies the quality of care and treatment through a recognized and skillful method. It was approved in 2022  by the United States Patent and trademark office  Office approved HPV BCR in 2021

The trademark registration for HPV BCR was approved by the US Patent and Trademark Office in 2022.

In 2024, the Mayor of Los Angeles along with all 15 council members signed a recognition award for Dr. Arani for his medical contributions regarding HPV and his innovative HPV BCR treatment methods. This award was presented to him in a special ceremony that was featured in the media.